According to Frost & Sullivan, to tap into the growth prospects exposed by the CGT market, businesses must focus on: Developing manufacturing platforms capable of producing high volumes of clinical-grade products while keeping costs down. Partnering with CDMOs to transition smoothly from laboratory scale to commercial production with greater consistency. Implementing a hub-and-spoke approach toward […]